Continuous Infusion Low-Dose Unfractionated Heparin for the Management of Hypercoagulability Associated With COVID-19.

Matthew LiSteven GitartsAkwe NyaberaRavali KondaveetiYousef HammudehCarlos GonzalezTheo TrandafirescuArunakumari PenumaduRicardo LopezAsad SahibzadaAngel De La CruzHabibur Rahman

Published in: Journal of pharmacy practice (2020)

Continuous infusion of UFH for patients with COVID-19 infection did not decrease the overall incidence of thromboembolic complications. UFH was associated with stabilization of D-dimer concentrations and increased rates of minor bleeding and transfusions.

Keyphrases

low dose
risk factors
coronavirus disease
atrial fibrillation
high dose
sars cov
venous thromboembolism
growth factor